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ABSTRACT
Polaki, Venkata Sai Usha Sri. M.S., Department of Pharmacology and Toxicology,
Wright State University, 2020. Role of exercise in macrophage polarization of
perivascular adipose tissue and adipose tissue inflammation in hypertensive mice
model.

Hypertension, also known as high blood pressure, is a long-term medical condition in
which the blood pressure in the arteries is persistently elevated. It can lead to severe
health complications and increase the risk of heart disease, stroke, and sometimes death.
Perivascular adipose tissue (PVAT) is known as the adipose tissue (AT) surrounding
all the blood vessels and plays a critical role in the pathogenesis of the vascular disease.
In vascular pathologies, PVAT increases in volume and becomes dysfunctional, with
altered cellular composition and molecular characteristics. Macrophages have been
found to accumulate in PVAT during hypertension, which might be involved in the
inflammation of hypertension. Inflammation has been shown to play an important role
in hypertension; however, the exact mechanisms by which the activated immune cells
partly lead to the development and maintenance of hypertension remain to be
elucidated. The objective of this study is to determine the role of exercise in the
inflammation of AT and PVAT by modulating the polarization of macrophages in
hypertensive mice. Renin transgenic (R+) mice have been used as a hypertensive mice
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model. The PVAT, AT, and plasma samples were collected for the analysis of
inflammatory cytokines, macrophages isolation, and polarization. The release of
cytokines from AT and PVAT was determined by ELISA and the release of cytokines
from plasma was determined by bio plex cytokine analysis. Our ELISA results did not
show the changes of exercise on the release of cytokines in AT but could decrease the
pro-inflammatory cytokines in PVAT. While our flow cytometry results showed that
exercise affected the macrophage polarization in adipose tissue but not in PVAT.
Cytokine analysis of plasma samples showed a decrease in pro-inflammatory cytokines
IFN-g and IL-6, as well as anti-inflammatory cytokines IL-4 and IL-13, while an
increase in IL-10 was noted, which might be related to effects of exercise by alleviating
the release of cytokines. Very interestingly, we found that exercise also decreased
vascular remodeling in the aorta. In conclusion, our data suggest that exercise might
have effects on alleviating inflammation and modulating the polarization of
macrophages in AT and PVAT of R+ mice. Further studies and more animal numbers
are needed to confirm the protective effect of exercise in modulating the macrophage
polarization in the hypertensive mice model.
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I.

INTRODUCTION

1. Hypertension:
1.1. Definition, prevalence, types
The pressure of blood pushing against the wall of arteries is termed as blood
pressure. It is termed as systolic pressure in the numerator and diastolic pressure
in the denominator. Blood pressure in a healthy individual is 120/80. However,
blood pressure keeps varying throughout the day, and it is termed as high blood
pressure or hypertension when it raises consistently than the normal blood
pressure [1,2]. According to WHO, 1.13 billion people worldwide are known to
have hypertension. In 2015, 1 in 4 men and 1 in 5 women were known to have
hypertension. In 2017, the American College of Cardiology and the American
Heart Association published new guidelines for hypertension management and
defined high hypertension as blood pressure at or above 130/80 mm Hg. Also,
stage 2 hypertension is defined as blood pressure at or above 140/90 mm Hg. In
2017, nearly half a million deaths in the United States were included due to
hypertension as a primary or contributing cause.
Nearly half of adults in the United States (108 million, or 45%) have
hypertension, which is defined as a systolic blood pressure ≥ 130 mm Hg or a
diastolic blood pressure ≥ 80 mm Hg or are taking medication for hypertension.
Only about 1 in 4 adults (24%) with hypertension have their condition under
control [4,5]. The prevalence of hypertension has to be decreased by 25% by 2025
(baseline 2010). Justin Rucker et.al termed hypertension as a global pandemic, if
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untreated, it may lead to end-organ damage commonly known as congestive heart
failure, myocardial infarction, stroke, and chronic. kidney disease. About 27% of
Africans, 25% of southeast Asians, 26% of eastern Mediterranean’s, and 25% of
southeast Asians have been recognized with hypertension while 18% of
Americans, and 19% of western Pacific’s, and globally 22% of the population is
prevalent with hypertension. The number of adults with hypertension in 1975 was
594 million, which increased to 1.13 billion in 2015, and that this increase is seen
mainly in countries with low and middle-income countries [6].

1.2. Classification:
Hypertension mainly has two types, primary hypertension which is also called
essential hypertension seen in 95% of the people and secondary hypertension.
Primary hypertension or essential hypertension:
If the blood pressure is high for more than three measurements, it is diagnosed
as primary hypertension. The cause is unknown, but it mostly occurs with
headaches and tiredness.

Secondary hypertension:
The cause is known which includes obstruction in the blood vessels supplying
blood, consumption of salt and alcohol in the diet, sleep, and hormone disorders,
and consumption of certain drugs. Once diagnosed, secondary hypertension can
be controlled by various methods.

Other types:
Isolated systolic hypertension:
2

When the systolic pressure exceeds 140 mm. Hg and the diastolic pressure is
below 90mm Hg, it is characterized as isolated systolic blood pressure. It is
caused when the blood vessels lose their elasticity and are usually seen in people
above 65 years of age.

Malignant hypertension:
It occurs when the diastolic pressure rises above 130 mm Hg. It is seen in 1% of
people with hypertension and is mostly seen in younger adults, AfricanAmerican men, and in women who have pregnancy toxemia. The symptoms
include headache, blurred vision, confusion, and numbness in the hands and
legs.

Resistant hypertension:
If the blood pressure is consistently high even after taking the medication, it is
termed as resistant hypertension. About 20-30% of people with hypertension are
diagnosed with resistant hypertension. It is seen in people with obesity, African
Americans, older people, people suffering from diabetes, and kidney disease
[7,8].
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Figure 1. Hypertension. Blood vessel depicting normal, Prehypertensive, hypertensive
conditions [9].

1.3. Screening and diagnosis:
According to the U.S. preventive task force and Screening, it is recommended for
all the adults above 18 years of age to undergo screening every two years and for
people with blood pressure less than 120/80, and annual screening for people with
blood pressure above 120/80 [11,12]. Most of the patients having high blood
pressure would be unaware of their symptoms. Hence hypertension is called a
“silent killer”. It is diagnosed with the symptoms of severe headache, blurred
vision, and irregular heart rhythms. Severe hypertension symptoms include
nausea, vomiting, confusion, and anxiety [13].
According to the fluctuations in blood pressure, hypertension is classified as
follows:
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Figure 2. Classification of hypertension [10].

1.4. Risk factors and treatment:
There are various underlying risk factors that are responsible for hypertension,
which being classified as modifiable and non-modifiable. Modifiable risk factors
are amenable to intervention or treatment, which include excessive intake of salt,
tobacco, alcohol, physical inactivity, and overweight. Non-modifiable risk
factors, on the other hand, are seen only if there is a family history of hypertension
[14,15]. The main aim of the treatment of hypertension is to lower blood pressure.
It can be done by either lifestyle intervention or by pharmacotherapy. Early
Lifestyle modification can reduce the risk of hypertension, and this may also
reduce the chance of giving pharmacotherapy [16]. Report seven by Joint
National Committee (JNC) on prevention, detection, evaluation, and treatment of
hypertension for all pre-hypertension and hypertensive patients suggests lifestyle
modifications such as weight loss, reduce intake of salt, physical activity, and
reduction in the consumption of alcohol. The pharmacotherapy includes antihypertensive medications like angiotensin receptor blockers (ARBs), ACE
inhibitors, beta-blockers, and calcium channel blockers [17].
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2. Adipose tissue:

2.1. Types and function:
Adipose tissue is distributed all over the body, and it is characterized into white
adipose tissue (WAT) and brown adipose tissue (BAT), of which 20 -25% of the
total body weight constitutes WAT. Adipose tissue was previously known to be
a protective layer, but recent studies have shown that adipose tissue plays a role
as an endocrine organ. Dysfunctional adipocytes or adipocyte hypertrophy may
lead to excessive secretion of adipokines and cytokines. BAT produces heat by
uncoupling oxidation on the electron transport chain which stops the
accumulation of lipids [18,19,20].
Besides the white adipose tissue and the brown adipose tissue, another type of
adipose tissue exists which is termed as beige fat. It is also called browned fat or
bright fat (which means brown in white). Beige adipocytes as their name suggest,
are brown adipocytes with the classical white adipose tissue deposits. There is
still debate about the origin and the function of the beige adipocytes. They are
known to be formed by denovo adipogenesis by few progenitor cells stimulated
by cold exposure but become dormant until there is another stimulation. This
transformation of dormant cells to active cells is called trans differentiation of
white to beige adipocytes. [21,22].
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Adipocytes are one of the main cell types in adipose tissue along with endothelial
cells, vascular smooth muscle cells, macrophages, and fibroblasts. Apart from the
differentiation of adipose tissue based on the color, it is also divided based on the
location that it is surrounded such as internal organs (visceral adipose tissue),
underneath the skin (subcutaneous adipose tissue), and around blood vessels
(perivascular adipose tissue) [23,24].

Figure 3. Types of adipose tissue [25].

2.2. Perivascular adipose tissue (PVAT):
Most blood vessels are surrounded by a variable amount of adipose tissue outside
the adventitial layer. It is mostly white fat except the PVAT surrounding the aorta
where it usually consists a mixture of both white and brown fat [26,27,28]. PVAT
is known to communicate with the other layers of the vessel. Paracrine effects are
shown directly on vascular smooth muscle cells in the medial layer and
endothelial cells in the intimal layer. PVAT’s endocrine actions are seen in
regulating the vessel tone or during some disease state [29,30].
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Figure 4. Types of perivascular adipose tissue [31].

3. Renin-angiotensin system (RAS):

The Renin-angiotensin system plays an important role in maintaining sodium
electrolyte balance, blood pressure, and fluid volume. Renin is produced from
kidneys in a proactive form and is converted to its active form once it reaches the
circulation by various proteolytic and non- proteolytic mechanisms. Renin helps
in the conversion of angiotensinogen to Angiotensin (Ang)- I, which is converted
to Ang-II by Angiotensin-Converting enzyme (ACE) which is produced from
lungs. Ang-I is converted to Ang 1-7 by endopeptidases which had the opposite
effects of Ang-II. The effects of Ang-II are mediated through the binding of the
Ang-II type 1 receptor. It can also bind to the Ang-II type 2 receptor and show
the opposite effects of Ang-II type 2 receptors. Ang 1-7 can be produced by the
cleavage of Ang-II by ACE-2, which results in vasodilation [32].

3.1. RAS in hypertension:
The actions of RAS in maintaining sodium electrolyte balance, blood pressure,
and fluid volume are mainly executed by Ang-II. Ang-II is a vasoconstrictor,
8

while Ang 1-7 is known to antagonize the effects of Ang-II [51]. Ang-II infused
models are known to play an essential role in RAS and hypertension research.
Hypertensive models are known to show increased expression of Ang-II and
decreased expression of Ang 1-7. Rats infused with Ang-II have high blood
pressure with increased angiotensinogen, Ang-II, and intrarenal renin are
decreased upon the blockade of the AT1 receptor, indicating that activation of
RAS occurs in Ang-II depends on the AT-1 receptor. This results in different
levels of Ang-II in plasma and kidney. Renin in juxtaglomerular apparatus and
plasma is decreased in this hypertensive model, while in the distal tubule Ang-I
and Ang-II are increased resulting in increased blood pressure. Importantly,
transgenic mouse lines are made with different lengths of the human renin gene
locus where they express human prorenin, which itself may have distinct and
significant biological activity, and human renin. Lavoie et al. created a double
transgenic

hypertensive

mouse

model

by

co-expressing

renin

and

angiotensinogen [89]. As the production of renin and angiotensinogen is twice,
the effect is said to be doubled, and that this could be a cause of systemic
hypertension. Spontaneously Hypertensive Rats (SHR) are also used as a genetic
model for hypertension. This model showed an increase in the intrarenal
angiotensinogen resulting in increased Ang-II and tissue damage [33]. Renin
transgenic mice are known to overexpress renin, and thus are valuable for studies
of human renin gene regulation and RAS physiology when they are crossed to
transgenic mice that express human angiotensinogen. Renin transgenic mice
express renin at a constant level in the liver which leads to increased plasma levels
of prorenin and active renin. They express high blood pressure, enhanced thirst,
high urine output, proteinuria, and kidney damage [90].
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3.2. RAS in adipose tissue:
Studies have shown that adipose tissue is a major source for angiotensinogen
other than the liver [24]. Ang-II is known to hinder the conversion of preadipocytes to adipocytes resulting in large and dysfunctional adipocytes, and the
angiotensinogen levels are uplifted in the adipocytes. Evidence suggests that large
adipocytes are enriched with leptin, reactive oxygen species (ROS), and proinflammatory cytokines [34,35]. Large adipose tissue is known to be infiltrated
by macrophages. Macrophages produced from adipocytes release various
cytokines [36,37]. Renin was also found to be present in adipose tissue, mostly in
the stromal fraction. A study depicted that during the differentiation of stromal
cells, the mRNA of the renin receptor was decreased while the protein content
was the same, which depicts post-transcriptional regulation. Visceral adipose
tissue was known to show increased expression of renin than subcutaneous
adipose tissue in both lean and obese conditions. Adipose tissue inflammation is
known to be a connecting link between obesity and many other inflammatory
disorders. Since AT1 and AT2 are expressed in adipose tissue, by releasing
chemokines and an increase in oxidative stress, Ang-II is known to cause
inflammation in the adipose tissue. Both protein and mRNA of MCP-1 was
increased by Ang-II in the pre-adipocytes of rat [40].
While in PVAT, the presence of components of RAS varies in white and brown
PVAT. [51]. Angiotensinogen and Ang-1 are similar while the presence of Ang2 varies in both white and brown adipose tissue [51]. However, there is no
evidence with the presence of renin in both white and brown PVAT [51]. Also,
Ang 1-7 released by PVAT acts to stimulate the release of nitric oxide (NO) on
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the endothelium which is found to be the important product from RAS in
PVAT[51].

Figure 5. RAS in adipose tissue [41].

4. Role of adipose tissue inflammation in hypertension:

4.1. Adipose tissue inflammation:
Adipose tissue is not only an energy storage site but also known to secrete
paracrine, endocrine, and autocrine molecules. WAT is known to be infiltrated
with inflammatory cells like the macrophages during hypertension. In WAT,
lipotoxic effects are seen where the ability to metabolize fats is above the limit
which results in the accumulation of immune cells like the macrophages [42, 23]
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Figure 6. White Adipose Tissue inflammation-causing release of different cells and endorgan damage.

Increasing in the composition of WAT is known to affect the blood pressure. It
releases different molecules like ROS, proinflammatory cytokines, and free fatty
acids. Release of these molecules results in increased blood pressure by causing
vasoconstriction and decreased vasodilation, fluid retention, and vascular
remodeling. Along with WAT, molecules secreted from BAT also contribute to
the elevation of blood pressure [23].

Figure 7. Brown Adipose tissue inflammation and its complications.
12

4.2. Perivascular adipose tissue inflammation:
PVAT is known to be the primary site of initial inflammation in hypertension
[43,44]. ROS from PVAT causes endothelial dysfunction, which is mediated
either by the changes in the perivascular inflammation[45,46]. In a condition like
hypertension, as the disease progresses, size and amount of PVAT are decreased,
immune cells accumulate in the PVAT surrounding aorta and mesenteric arteries
[47,48,49]. In dysfunctional adipocyte, the levels of adiponectin are decreased
while the pro-inflammatory cytokines are increased, showing the proinflammatory effect [50,51]. PVAT like other adipose depots is known to undergo
hypertrophy and becomes dysfunctional in many disease conditions. Once the
inflammation is initiated, there is a release of a variety of cytokines and
chemokines like MCP-1 which helps in recruiting cells, macrophages, and
monocytes. Dysfunctional PVAT causes the excessive release of cytokines which
are more pro-inflammatory than anti-inflammatory cytokines. Immune cells
present in dysfunctional adipose tissue are T-cells, B- cells, macrophages, and
dendritic cells [28,43,44].

Figure 8. Immune cell infiltration perivascular adipose tissue in conditions like
hypertension [53].
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Figure 9. Inflammation of perivascular adipose tissue and its effects [51].

5. Macrophages:

5.1. Role and function:
About 10-15% of the stromal vascular fraction contributes to macrophages [54].
Macrophages help in the detection, phagocytosis, and removal of bacteria, as well
as present antigen to T- cells and initiate inflammation by releasing cytokines
[55,56]. Macrophages show a differential degree of heterogeneity based on the
morphology and the type of cytokines they produce. Macrophages circulate to all
the tissues for phagocytosis [57]. Different macrophages play different roles
based on the tissue they circulate to as the alveolar macrophages present in the
lungs, Kupffer cells present in the liver, microglia present in the central nervous
system, splenic macrophages present in spleen marginal zone, red and white pulp
[58,59]. Macrophages show phagocytosis by binding to receptors like the Tolllike receptors [60].
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5.2. Macrophage polarization:
Immune cells are known to play a very important role in the pathophysiology of
hypertension. Macrophages are the earliest cells in many tissue types and during
hypertension, they are known to exhibit a degree of plasticity, which is displayed
as a functional and phenotypic differentiation termed as polarization (M1 and M2
phenotypes). Apart from the role in the immune system, macrophages play a role
in homeostasis [61,62,63].

5.3. Types of macrophages:
There are two different types of macrophages: M1 and M2. The idea was known
when macrophages showed differences in the effects when exposed to interferongamma than to IL-4 [64,65]. Interferon-gamma (IFN-g) causes the differentiation
of M1 macrophages which are inflammatory and are termed as classically
activated macrophages. IL-4 induces the differentiation of anti-inflammatory M2
macrophages, and this is termed as alternatively activated macrophages which are
further subdivided into M2a, M2b, M2c, M2 d. The differences between the two
populations are dependent on the differentiation of T-lymphocytes. M1
phenotypes activate Th1 T-lymphocytes and the M2 phenotype activates Th2 Tlymphocytes. In a study performed in 45 hypertensive patients, it was found that
Th1 T-lymphocytes and Th 17 T-lymphocytes were more when compared to Th2
T-lymphocytes (Ji et al) [61]. Another study conducted by Guzik et al. used a
RAG KO murine ANG-II dependent model and confirmed the presence of effect
on ANG-II on T-lymphocytes. M1 phenotype is said to metabolize L-arginine to
nitric oxide (NO) through inducible nitric oxide synthase (iNOS) while the M2
phenotype is known to metabolize L-arginine to ornithine which helps in the
15

promotion of tissue repair, and growth by the activation of arginase-1 (Arg1).
Other components include NO and ROS, a decrease in the NO levels was
observed in many hypertensive models, ROS is not only found to be a major
factor in the pathophysiology of hypertension it is also known to cause end-organ
damage. ROS, a product of the M1 phenotype of macrophages is known to
scavenge NO availability. M1 macrophages are identified by CD86, major
histocompatibility complex II (MHC II), CD80/86, Ly6, CD62L, CC chemokine
receptor 2 (CCR2 a receptor for MCP-1). M2 macrophages are identified by
CD206 (mannose receptor), CD163 (scavenge receptor), vascular endothelial
growth factor (VEGF), YM1 and YM2 (chitinase group), and acid mammalian
chitinase group. Both the phenotypes exhibit different cytokine and chemokine
profiles. M1 phenotype secretes pro-inflammatory cytokines like TNF-alpha, IL6, IL-23, IL-18, and IL-12, and that these result in the development of not only
Th1 T-lymphocytes but also TH-17 T-lymphocytes. M2 macrophages secrete
anti-inflammatory cytokine IL-10, tumor growth factor (TGF-beta) which
activates regulatory T-lymphocytes (Tregs). It was found that in the experimental
models of hypertension, the Tregs is decreased. It was also proved that the
presence of the anti-inflammatory cytokines protected the organ system from
damage [61].
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Figure 10. Macrophage activation and release of different cytokines [66].

6. Stages of macrophage recruitment to the adipose tissue:

Three basic stages for the recruitment of macrophages in the adipose tissue are
reported as follows:
i)

Initiation:
As the body weight increases, adipocytes undergo hypertrophy and
hyperplasia. As a result of hypertrophy, fatty acid influx, vascularization,
increase in the secretion of leptin, and hypoxia cause adipocyte cell death
to occur Capillary endothelial cells and adipocytes are involved in this
process.

ii)

Propagation of macrophage recruitment in the tissue:
Macrophages from the adipose tissue themselves release different signals
or factors like chemokines that help in further accumulation of
macrophages. Chemokines are cytokines of 8-10 kDa which help in
mobilizing the macrophages from bone marrow to various tissues during
inflammation, this is termed as the propagation of macrophages to the
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tissue. There are a lot of other factors as well, but chemokines are known
to be the primary mediators to help in the recruitment of macrophages.
iii)

Remodeling of adipose tissue:
Once the macrophages get recruited or accumulated in the tissue, they
help in the remodeling and repair of the adipose tissue showing their
distinct characteristic known as “MACROPHAGE POLARIZATION”.
The apoptotic or the dead cells are known to transform the macrophages
and show anti-inflammatory effects. Both M1 and M2 macrophages help
in controlling the inflammatory profile of the tissue. Adipose tissue
remodeling could be due to the vascularization and tissue inhibitor of
matrix metalloproteinase system.

Figure 11. Stages involved in macrophage infiltration Pictorial representation [67].

7. Physical activity:

Exercise is one of the primary non-pharmacological therapies or is also said to be
lifestyle modification therapy in the treatment of hypertension. Studies have
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shown the beneficial effects of physical training on hypertension by a decrease of
5-7 mm Hg [68,69 70, 71,72]. Acute exercise results in an immediate decrease in
blood pressure termed as post-exercise hypotension. Chronic exercise results in a
persistent decrease in blood pressure. This decrease is due to the changes in the
peripheral vascular resistance. Also, the effect of exercise on hypertension may
vary according to the exercise protocols, environmental, or external factors [73].
Different factors are taken into consideration for exercise like the modality,
intensity, time, frequency, and the duration for advantageous effects of exercise.
Exercise training is of three different types, namely dynamic, static, and resistive.
Dynamic exercise works for people who have CVD, however, static and resistive
exercise work for people who are already being treated. Intensity is categorized
into low, medium, and high. It is measured by recording an oxygen uptake (VO2)
and maximum oxygen uptake (VO2 max). Time that exercise lasts like the days
or months is categorized as a short-term, medium-term, and long-term [74].
Animals used for experimental research are mouse, and rat due to their ability to
produce more offsprings and short gestation periods. Training includes
swimming, walking, voluntary wheel running, and treadmill exercise
[75,76,77,78,79].

Figure 12. Modalities of exercise [80].
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American heart association suggests that at least 150 minutes of moderateintensity aerobic exercise in a week or 75 minutes of high-intensity aerobic
activity or both thorough out the week are required for beneficial effects.
Importantly, exercising for about 300 minutes per week (5 hours) yields more
benefits [81].

7.1. Effect of exercise on macrophage polarization, inflammation, and hypertension:
The exercise shows effects on adipocyte-specific genes which express AMPK,
and PGC-alpha, which increases beta-oxidation and mitochondrial biogenesis.
Increased mitochondrial biogenesis results in decreased oxidative stress and proinflammatory cytokines then polarize macrophages to the M1 phenotype.

A. Hypertension

B. Exercise/ exercise training

Figure 13. Effect of exercise on adipose tissue and macrophage polarisation.

7.2. Beneficial effects of exercise include:
1) The Decrease in the fat mass
2) Decreased TLRs on monocyte and macrophages
3) Increased anti-inflammatory cytokines
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4) Inhibition of macrophage infiltration and phenotypic switch of macrophages
from M1 to M2 phenotype [82]. Randomized control trials have been performed
and the meta-analyses of these studies show that aerobic exercise decreases blood
pressure up to 5-7 mm Hg [83,84,85]. While dynamic exercise up to 2-3 mm Hg
[75,83,85-88]. A randomized trial concluded that the rate of decrease in blood
pressure caused after exercise was more when compared to the anti-hypertensive
drugs and that the aerobic exercise must be considered a factor in lowering blood
pressure.
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II.

HYPOTHESIS AND SPECIFIC AIMS

1. Hypothesis:
Exercise decreases inflammation of perivascular adipose tissue and adipose tissue
by modulating macrophage polarization in hypertensive mice.

2. Specific aims:
Aim 1: To confirm the inflammation in PVAT/AT in hypertensive mice:
To determine the inflammatory cytokines and phenotype of macrophages
(M1/M2) in PVAT/AT samples collected from the control and hypertensive mice
before exercise.
Aim 2: To confirm whether exercise provides protective effects on PVAT/AT
inflammation:
To determine the inflammatory cytokines and phenotype of macrophages
(M1/M2) in PVAT/AT samples collected from the control and hypertensive mice
after exercise.
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III.

EXPERIMENTAL DESIGN

Control group:

ELISA and
flow
cytometry

Collect
PVAT/AT
, plasma
samples

Normal
Mice

Hand E staining

Bioplex cytokine
analysis

Hypertensive
mice

Test group:

Collect
PVAT/AT
, plasma
samples

8/4 weeks
Hypertensive
mice(start point)

Exercise mice- 5 days/
week for 1 hour

Figure 14. Pictorial representation of the experimental design.

23

ELISA and
flow
cytometry
H and E
staining

Bio plex cytokine
analysis

IV.

MATERIALS AND METHODS

1. Animals
Five weeks old male and female renin transgenic (R+) mice and their matched
control littermates were bred in the Laboratory Animal Resource (LAR) facility.
Animals were housed in standard cages at 22˚c under a 12- hour light/12-hour
dark cycle with ad libitum access to water and standard mouse chow. All
experimental procedures were performed at Wright State University laboratory
animal care and use committee and were in accordance with the guide for the care
and use of laboratory animals issued by the National Institute for Health.

2. Exercise procedure and group information
Mice (5-7 weeks old) were divided into 3 different groups:
1) Normal mice without exercise (control group)
2) Renin transgenic mice without exercise (R+ no exercise)
3) Renin transgenic mice with exercise (R+ exercise)
Exercised mice were subjected to exercise training for one week on a mouse
forced treadmill for one hour per day, five days a week. The Initial speed was set
at 6.0 meter/minute and gradually increased by 1 meter/ minute until 10 meters/
minute by the end of the training. In the subsequent exercise group, mice were
run at 10 meters/minute, one hour per day, five days a week for 8 weeks. All mice
were monitored weekly for body weight. At the end of the experiment, blood
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samples, adipose tissue, and perivascular adipose tissue samples were collected
for flow, ELISA, H& E staining, and bio-plex cytokine analysis.

3. Isolation of adipose tissue and perivascular adipose tissue
After 8 weeks of exercise, mice were anesthetized with 0.1mg/g ethanol by i.p.
injection (intraperitoneal route). Once the mice were under deep anesthesia, a
midline incision was made in the thoracic cavity to expose the abdomen. Cardiac
perfusion was performed by using 1X PBS to remove all the blood, followed by
the 4% paraformaldehyde to pre-fix the samples. The adipose tissues from the
abdomen and the PVAT were collected and weighed. The tissue was rinsed with
PBS to remove any contaminants, such as fur, and placed in lysis buffer for
protein extraction or in formalin for histology process.

4. Protein concentration analysis
The adipose and perivascular adipose tissues were placed in lysis buffer and
sonicated for 5 sec. After sitting on ice for 30 min, the samples were centrifuged
at 10000 x g for 15 min and the supernatant (protein) was collected into a new
microfuge tube and stored at -80˚c. The concentration of the protein was
determined by BCA assay.

5. Blood and plasma collection
Blood was collected from the heart of mice using a 1ml syringe containing a
small amount of 0.5M EDTA for anticoagulation. Blood samples were
centrifuged at 2000 x g for 10-15 min. Plasma is was immediately separated and
stored frozen at -80°c for future use.
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6. HE staining
Aorta was fixed in 10% formalin overnight and embedded in paraffin the next
day. Tissue samples were cut into 10 um of sections and mounted on slides. Slides
were dewaxed in xylene and rehydrated in graded alcohols. The slides were then
stained in hematoxylin solution for 15 min washed in double-distilled water for 1
min. After rinsing in water, the slide was placed in Scott’s tap water substitute
(1:10) for 5 sec. A subsequent rinse was done in water and then stained with an
eosin solution for 1-2 min. The slide was rinsed in xylene again and subjected to
different grades of alcohol to rehydrate. Images were taken on a confocal laser
scanning microscope (Olympus). Image J software was used to measure the
remodeling of the aorta (wall/lumen ratio).

7. Flow cytometry
Adipose tissue and PVAT were minced using digestion buffer (2mg/ml of
collagenase in hanks balanced salt solution with ca+2 and mg+2 supplemented
with 0.5% bovine serum albumin, Sigma-Aldrich; catalog no: c6885). The tissue
was then incubated at 37˚c for 90 min with vigorous shaking for every 5 min.
After digestion, EDTA (10 mM) was added and incubated at 37˚c for an
additional 5- 0 min. A 100 um nylon filter was prewet with PBS and placed on a
conical tube. The bottom layer of the slurry was transferred onto the filter
followed by adipocyte containing the upper layer. Then the cell slurry was
centrifuged at 500xg for 10 min at 4˚c to separate adipocytes with the stromal
vascular cells. After centrifugation, the adipocytes form a white layer and the
stromal vascular cells form a red/ white pellet on the bottom of the tube.
Adipocytes and supernatant were gently aspirated and discarded. The pellet was
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disrupted by flicking the tube and resuspended in 0.5ml red blood cells (RBC)
lysis buffer and incubated at room temperature with occasional shaking. RBC
lysis buffer was prepared with 155 mM NH4CL, 10 mM KHCO3, 0.1 M EDTA;
sterile-filtered through 0.22um filter, and stored in aliquots at 4˚c. RBC lysis
buffer was neutralized by adding 5ml of FACS buffer which was prepared with
PBS with 1 mM EDTA, 25 mM HEPES and 1% heat-inactivated fetal bovine
serum (FBS). The solution was centrifuged at 500x g for 10 min at 4˚c in MACS
buffer. (MACS buffer: PBS without ca+2 and mg+2 supplemented with 0.5%
BSA.) Cells were suspended in 90 ul of PBS and incubated with F4/80-FITC (20
ul, BD), CD206-APC (20 ul, BD), and of CD86-PE (10 ul, BD). Samples were
analyzed by an Accuri C6 flow cytometer and C flow plus analysis software.

8. ELISA
Mouse IL-6 ELISA kit (catalog no: LS – F31580) and mouse IL-10 ELISA kit
(Catalo no: LS- FS24828) from life span bioscience was used to quantify the
concentration of IL-6 and IL-10 in AT and PVAT. The procedure was performed
according to the manufacture’s protocol. All the samples and reagents were
brought to room temperature 30 min before the experiment and were mixed
gently. Standard solution and samples (100 ul/well) were added into the well and
incubated for 90 min at room temperature. Then the liquid was aspirated, and
each well was washed 3 times with wash buffer. After the wash, 100ul of
biotinylated detection antibody working solution was added to each well and
incubated for 1 hour at 37 ˚c. The liquid was again aspirated and the plate was
washed three times. Then, 100 ul of HRP- Streptavidin conjugate working
solution was added and incubated for 45 min at 37˚c. The solution was aspirated

27

and the plate was washed 5 times. Then, TMB substrate was added and incubated
for 30 min at 37˚c in the dark. Stop solution (100ul) was added and the optical
density of each well was determined at 450 nm immediately using a plate reader.
A Standard curve with the known concentration of IL-10 and IL-6 was used as a
reference for the calculation of actual calculation.

9. Bio-plex cytokine analysis
Bio-plex cytokine assays [Bio-plex 200 Pro Mouse Cytokine Grp I Panel (23Plex)] are performed according to the manufacture’s protocol purchased from
Bio-Rad. Twenty-three

cytokines were analysed as a mixture of pro-

inflammatory cytokines and anti-inflammatory cytokines: IL-1a(53), IL1b(19),IL-2(36),IL-3(18), IL-4(39), IL-5(52), IL-6(38), IL-9(33), IL-10(56), IL12p40(76), IL-12p70(78), IL-13(37), IL-17 A(72), eotaxin(74), G-CSF(54), GMCSF(73), IFN-g(34), KC(57), MCP-1(51), MIP-1(51), MIP-1 a(77), MIP-1
b(75), RANTES(55), TNF-a(21).

10. Metabolic cages:

By the end of each week of exercise, the mice were housed in metabolic cages
individually overnight during the exercise (three weeks). The animals have free
access to food and water. The next day, urine was collected into a 15 ml falcon
tube and stored in -80 ˚c. Food and water consumption were recorded.
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11. Statistical analysis:

Data are represented as mean ± SEM. Multiple comparisons among the groups
were carried out by two-way ANOVA followed by post-hoc Tukey’s test. A value
of p<0.05 was considered significant. All the statistical analyses were performed
using Graph pad prism 8 software
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V. RESULTS

1. Effect of exercise on body weight:

The body weights of the mice in different groups were measured every week. As you
can see from the pictures of figure15 a and b, the size of hypertensive mice is slightly
smaller than the control mice as the summarized data show similar results (Fig. 16).
Results showed that there is no significant difference between the different groups.
However, we can see an increase in the body weight in exercise groups when compared
to hypertensive mice without exercise. As we mentioned before the size of hypertensive
(R+) mice was smaller than the controls. Results suggest that exercise might help the
growth of hypertensive mice.

.

Figure.15. a) C57 mice

b)
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R+ + mice

Figure 16. Depicting body weights of all the three groups of mice. Data are
represented as mean ± SEM. n=3 for control, n= 8 for R+ + no exercise, n=9 for R+ +
exercise. P< 0.05(*), P< 0.01(**), P<0.001(***), P<0.0001(****) and not
significant (ns) if P>0.05.

2. Bodyweight changes in hypertensive mice before and during exercise:

Bodyweight of the mice was recorded before and by the end of each week of exercise.
The results (Fig. 17) showed that there is a gradual increase in the weights of the mice
by the end of the exercise when compared to the weights before exercise. As we
mentioned before, the size of the R+ mice was smaller than the control mice. The data
suggest that exercise might help in increasing the body weight of hypertensive mice.
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Figure 17. Bodyweight changes in hypertensive mice before and during exercise. The
figure showing a gradual increase in the bodyweight of hypertensive mice by the end
of 8 weeks of exercise. Data are represented as mean ± SEM. n=11 for R++exercise
mice. P< 0.05(*), P< 0.01(**), P<0.001(***), P<0.0001(****) and not significant
(ns) if P>0.05.

3. The effect of exercise on the weight of adipose tissue and perivascular adipose
tissue by normalizing to body weight:

Adipose tissue and PVAT were collected from mice after eight weeks of exercise and
weighed accordingly. To reveal the relationship of the weight of the adipose tissue and
perivascular adipose tissue to the bodyweight, we also calculated the ratio of adipose
tissue and PVAT weight to the bodyweight. As shown in Fig. 18, the ratio of adipose
tissue weight to body weight was decreased significantly in the exercised hypertensive
group compared to the control group.
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Figure 18 . Depicts the weight of adipose tissue and perivascular adipose tissue to the
bodyweight of R++ no exercise and R++ exercise. Data are represented as mean ±
SEM,. n=3 for Control, n=8 for R++ no exercise, R++exercise (n= 15). P< 0.05(*), P<
0.01(**), P<0.001(***),P<0.0001(****) and not significant (ns) if P>0.05.

4. Effect of exercise on protein levels in the adipose tissue and perivascular
adipose tissue:

The protein concentration was measured by using the BCA assay. Results (Fig. 19)
showed a significant decrease in the level of protein concentration of adipose tissue in
the exercise group when compared to the no exercise group. No significant differences
between control and R++no exercise or control versus R++ exercise group in the protein
concentration of adipose tissue. Results showed a significant decrease in the expression
of protein concentration of perivascular adipose tissue in the exercise group when
compared to the R ++ no exercise group. A significant increase was found between
control vs R ++ no exercise and control vs R ++ exercise in the protein concentration of
PVAT.
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Figure 19. Bar graph showing the levels of protein of adipose tissue and PVAT. Data
are represented as mean ± SEM. n=7 for control, n=7 for R++ no exercise, n=9 for
R++ exercise. P< 0.05(*), P< 0.01(**), P<0.001(***), P<0.0001(****) and not
significant (ns) if P>0.05.

5. Evaluation of structure of the aorta after exercise:

During the condition of hypertension, the vessels undergo vascular remodeling.
Sections of the aorta were stained with H and E to determine their structure and the
remodeling. Images were taken at 10x magnification and the remodeling (wall to lumen
ratio) was calculated using Image J. Results showed that the wall to lumen ratio was
decreased in exercised hypertensive mice when compared to control and no exercise
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hypertensive mice suggesting that the exercise influenced the vascular remodeling of
the hypertensive mice (Fig. 20).

control

R+ + no exercise

R+ + exercise

Figure 20. Representative images of aorta remodeling and the summarized data on
Wall/lumen ration changes after exercise. Data is represented mean ± SEM control
(n=5), R+ + no exercise (n=5), R+ + exercise (n=5), P< 0.05(*), P< 0.01(**),
P<0.001(***),P<0.0001(****). Control was normalized to 1 and the data are
expressed as fold of the control.

6. Effect of exercise on the release of cytokines in adipose tissue, perivascular
adipose tissue, and plasma samples:
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Various anti-inflammatory and inflammatory cytokines released from the macrophages
in the adipose tissue and perivascular adipose tissue and plasma samples were analyzed
by i) ELISA and ii) bio-plex assay. Samples were collected after 8 weeks of the exercise
along with the control group and hypertensive group of the same age. The cytokine
levels in the adipose tissue and perivascular adipose tissue were measured by ELISA,
while the level of cytokines in plasma samples was determined by bio-plex.

6.1. Effect of exercise on the levels of IL-6 and IL-10 in adipose tissue:
Protein concentration was determined by BCA assay and normalized to a protein
concentration of each sample. Results showed that exercise slightly decreases the level
of IL-6 in the adipose tissue in hypertensive mice (no significant difference). There was
a slight decrease in IL-10 levels in the hypertensive mice when compared to the control
mice. However, there was no significant difference. And exercise did not have any
effects on the IL-10 in the adipose tissue in hypertensive mice. For IL-6 and IL-10,
there were no significant changes in the levels of IL-6 and IL-10 in the adipose tissue
between hypertensive mice and control mice (Fig. 21).
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a)

b)

c)

d)
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Figure 21. Cytokine levels change in adipose tissue after exercise. a) Bar graph
showing the concentration of IL-6 in three groups of mice (control, hypertensive mice
without exercise (R+ + no exercise), hypertensive mice with exercise (R+ + exercise) in
adipose tissue. b) Bar graph showing the concentration of IL-10 in three groups of mice
in adipose tissue. c) and d) Bar graph showing the concentration of IL-6 and IL-10
normalized to the protein concentration of the tissue in three groups of mice. Data are
represented as mean ± SEM. n=6 for control, n=6 for R+ + no exercise, n=7 for R+ +
exercise. P< 0.05(*), P< 0.01(**), P<0.001(***), P<0.0001(****) and not significant
(ns) if P>0.05.

6.2. Effect of exercise on the levels of IL-6 and IL-10 in perivascular adipose
tissue:
As shown in Fig. 22, the IL-10 level was decreased in the PVAT in hypertensive mice.
More importantly, after normalizing with the concentration of perivascular adipose
tissue, we found that the exercise decreased IL-6 level in PVAT of hypertensive mice.
These results suggest that exercise might have a beneficial effect on the release of
cytokines in PVAT of hypertensive mice, but not in the adipose tissue.
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a)

b)

c)

d)

Figure 22. Cytokine levels change in perivascular adipose tissue after exercise. a) Bar
graph showing the concentration of IL-6 in three groups of mice (control, hypertensive
mice without exercise (R+ +no exercise), hypertensive mice with exercise (R+ +
exercise) in perivascular adipose tissue. b) Bar graph showing the concentration of IL10 in three groups of mice in perivascular adipose tissue. c) and d) Bar graph showing
the concentration of IL-6 and IL-10 normalized to the protein concentration of the
tissue in three groups of mice. Data are represented as mean ± SEM. n=7 for control,
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n=7for R+ + no exercise, n=7 for R+ + exercise. P< 0.05(*), P< 0.01(**),
P<0.001(***), P<0.0001(****) and not significant (ns) if P>0.05.

6.3. Effect of exercise on the release of cytokines in plasma:
The collected plasma samples were analyzed for different cytokines secreted by M1
and M2 phenotypes. Results (Fig. 23) showed that there was a significant decrease in
the level of IFN-γ between R+ +no exercise and R+ +exercise. However, the level of
IFN- γ was significantly decreased in R+ +no-exercise and R+ +exercise when compared
to control, while there were no significant differences between the groups for IL-12.
The levels of TNF-α showed a significant decrease in the exercise and no exercise
groups when compared to the control. While the anti-inflammatory cytokines IL-13 and
IL-4 were decreased significantly in both R++ no exercise and R+ +exercise when
compared to control, and there were no significant differences between the exercise and
no exercise groups. Moreover, IL-10 level was increased significantly after exercise
when compared to no exercise and control group, and there was no significant
difference between control and no exercise hypertensive group.
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a)

b)

c)

d)
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e)

f)

Figure 23. The release of different cytokines in the plasma was measured by bio
plex cytokine analysis. a) Bar graph showing the concentration of IFN-γ in three
groups of mice in plasma. n=7 for control, n=17 for R+ + no exercise, n=5 for R+ +
exercise. b) Bar graph showing the concentration of TNF-α in three groups of mice
in plasma. n=5 for control, n=6 for R+ + no exercise, n=4 for R+ + exercise. c) Bar
graph showing the concentration of IL-12 in three groups of mice in plasma. n=5 for
control, n=12 for R+ + no exercise, n=4 for R+ + exercise. d) Bar graph showing the
concentration of IL-13 in three groups of in plasma. n=5 for control, n=5 for R+ + no
exercise, n=4 for R+ + exercise. e) Bar graph showing the concentration of IL-4 in
three groups of mice in plasma. n=6 for control, n=6 for R+ + no exercise, n=4 for R+
+ exercise. f) Bar graph showing the concentration of IL-10 in three groups of mice
in plasma. n=5 for control, n=6 for R+ + no exercise, n=3 for R+ + exercise. P<
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0.05(*), P< 0.01(**), P<0.001(***), P<0.0001(****) and not significant (ns) if
P>0.05.

7. Effect of exercise on macrophage polarization in adipose tissue and
perivascular adipose tissue:

Flow cytometry is used to determine the type of markers and receptors on the surface
of the cells by using labelled antibodies. After 8 weeks of exercise, the number of
macrophages from all three groups of mice in both adipose tissue and perivascular
adipose tissue was analyzed. F4/80 positive cells were gated out from all the cells.
CD86 and CD206 markers were used to identify M1 and M2 phenotypes.

a)

b)
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c)

d)

Figure 24. The population of M1 and M2 macrophage in adipose tissue. a)
percentage of macrophages( F4/80+). b) percentage of M1 (CD 86+). c) the
percentage of M2 phenotype (CD 206+). d) the ratio of M1/ M2. Data are represented
as mean ± SEM. n=7 for control, n=10 for R+ + no exercise, n=4 for R+ + exercise.

a)

b)

Figure 25. Representative images of flow cytometry a) Representative plot of flow
cytometry for macrophages (F4/80+-FL1-H) in AT from exercised hypertensive mice.
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b) Representative plot of flow cytometry for M1 (CD 86 +-FL2-H) and M2 (CD 206+FL4-H) macrophages in AT from exercised hypertensive mice.

a)

b)

c)

d)
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Figure 26. The population of M1 and M2 macrophage in perivascular adipose tissue.
a) shows the overall percentage of macrophages( F4/80+). b) shows the percentage of
M1 (CD 86+). c) shows the percentage of M2 phenotype(CD 206+). d) shows the ratio
of M1/ M2. Data are represented as mean ± SEM. n=4 for control, n=5 for R+ + no
exercise, n=4 for R+ + exercise.

a)

b)

Figure 27. Representative images of flow cytometry a) Representative plot of flow
cytometry for overall macrophages(F4/80+-FL1-H) in PVAT exercised hypertensive
mice. b) Representative plot of flow cytometry for (CD 86 +- FL2-H) and (CD 206+FL4-H) in PVAT exercised hypertensive mice.

8. Effect of short-term exercise on metabolic parameters:

The animals were housed in metabolic cages and the food consumption was monitored
every week (Table 1). Overall, the results of the short term effect of exercise suggest
that there is no correlation between all the three parameters in different groups of mice.
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Parameters

control

R++ no exercise

R+ + exercise

Age (weeks)

6-7

6-7

6-7

Duration of exercise

3 weeks

3 weeks

3 weeks

Bodyweight(g) (week1)

25.17±0.920

18.67±0.6

21.85±1.478
5

Body weight(g) (week2)

24.6±0.50

19.67±0.38

21.33±0.5

Body weight(g) (week3)

24.53±0.189

20.33±0.5

20±0.54

Food intake(week1)

2.23±0.29

2.167±0.67

1.575±0.197

Food intake (week 2)

3.1±0.50

18.76667±16.08

1.125±0.30

Food intake (week 3)

4.733333±0.38

3.133333±1.068228

2.25±0.889288

Water intake (week 1)

5±0

5±2.886751

4.75±0.25

Water intake (week 2)

5.333333±0.19245

5.666667±1.347151

2.75±1.518406

Water intake (week 3)

3.666667±1.855921

8.333333±6.009252

5.5±1.658312

Urine output (week 1)

1.25±0.220479

0.916667±0.300463

0.916667±0.0
6

Urine output (week 2)

0.533333±0.050918

0.9±0

0.75±0.106066

Urine output (week 3)

2±0

0.55±0.159099

4.566667±2.14

Table 1. Short term effects of exercise (3-weeks) on metabolic parameters.

Data are represented as mean ± SEM. n=3 for control, n=3 for R+ + no exercise ,
n=4 for R+ + exercise.
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8.1 Effect of short term exercise on the consumption of food:
The food consumption of exercised mice decreased every week when compared to
control and hypertensive no exercise group. Exercise did not affect the consumption of
food in all three groups during the three weeks of exercise.

Figure 28. Depicting the consumption of food in all three groups of mice during three
weeks of exercise. Data are represented as mean ± SEM. n=3 for control, n= 3 for R+
+ no exercise, n=4 for R+ + exercise. P< 0.05(*), P< 0.01(**), P<0.001(***),
P<0.0001(****) and not significant (ns) if P>0.05.

8.2 Effect of short term exercise on the consumption of water:
Consumption of water decreased when compared to control and no exercise
hypertensive group by the end of week 1 and week 2. However, at the end of week 3,
consumption was decreased in exercised hypertensive mice when compared to
hypertensive mice and increased when compared to the control.
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Figure 29. Depicting consumption of water in all the three groups of mice during
three weeks of exercise. Data are represented as mean ± SEM. n=3 for control, n= 3
for R+ + no exercise, n=4 for R+ + exercise. P< 0.05(*), P< 0.01(**), P<0.001(***),
P<0.0001(****) and not significant (ns) if P>0.05.

8.3 Effect of short term exercise on urine output:
The results of urine output showed that at the end of the week 1 output of exercised
hypertensive mice was similar to no exercise group, urine output from both these groups
was decreased when compared to control. By the end of week 2, exercise mice showed
a decrease in the urine output when compared to the hypertensive mice and an increase
when compared to the control mice. Week 3 results show that there is an increase in the
output of urine in exercised hypertensive mice when compared to control and
hypertensive no exercise group.
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Figure 30. Depicting urine output in all three groups of mice during three weeks of
exercise. Data are represented as mean ± SEM. n=3 for control, n= 3 for R+ + no
exercise, n=4 for R+ + exercise. P< 0.05(*), P< 0.01(**), P<0.001(***),
P<0.0001(****) and not significant (ns) if P>0.05.
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VI.

DISCUSSION AND CONCLUSION

Exercise is known to show beneficial effects on vascular disease and hypertension [91].
However, the exact mechanisms of how it benefits the vascular system are still
unknown. Previous reports have shown that the content and size of the adipocytes are
changed after the exercise [92,93]. Hence, adipose tissue and perivascular adipose
tissue may play a role in maintaining the overall positive effect of exercise during many
cardiovascular disorders. Adipose tissue undergoes inflammation during hypertension
with an accumulation of macrophages and many other cytokines and chemokines [67].
After accumulated in the adipose tissue, macrophages undergo differentiation into M1
and M2 phenotypes [61]. The M1 phenotype has pro-inflammatory effects, while the
M2 phenotype has anti-inflammatory effects. In this study, we aimed to test whether
exercise has beneficial effects on inflammation in the adipose tissue and PVAT induced
by hypertension. We also looked into the mechanisms by focusing on the modulation
of the macrophage polarization and levels of the cytokines that are released by
macrophages. In this study, we used renin transgenic mice, as it has high blood pressure
with expressing renin at a constant rate in the liver which leads to elevated levels of
renin and prorenin in the plasma. They exhibit high thirst, high urine output, proteinuria,
and kidney damage. These mice were subjected to treadmill exercise intensity
(10m/min for 8 weeks, 5 days a week), which was based on our previous reports
showing the beneficial effects on the vascular diseases [94,95,96].
For the effects, we first measured the body weights of all the three groups of mice by
the end of 8 weeks of exercise to see the effect of exercise on the physiological paramete
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An increase in the body weights of the exercise group was observed when compared to
the control and the no exercise hypertensive group, while there were no significant
differences between the groups. On the other hand, we measured the body weights of
exercised hypertensive mice at the end of every week and found that exercise showed
a gradual increase in the hypertensive mice. As shown in the figures, hypertensive mice
are smaller than the control group due to their disease condition. Our data suggest that
exercise has an effect on the bodyweights of hypertensive mice. Along with the
bodyweights, adipose tissue weights and the perivascular weights were also measured
by the end of eight weeks. To reveal the relationship between body weight and adipose
tissue weights we normalized the weights with the body weights. The results suggest
that there is a relationship between adipose tissue weight, perivascular adipose tissue
weight with the bodyweight as there was a decrease in the ratio of AT/ body weight
and PVAT/ body weight in exercised group when compared to the hypertensive group.

In addition, we determined the protein concentration in the adipose tissue and PVAT.
Results from by BCA assay showed that the expression of the protein was decreased in
the exercise hypertensive group compared to the no-exercise hypertensive group, which
suggests a protective effect of exercise in hypertension.

As the vessel undergoes remodelling in hypertension [97], the previous studies have
shown that exercise induces vascular remodelling by inducing angiogenesis and
arteriogenesis [98]. Thus this was also our interest to see if exercise could provide
beneficial effects on vascular remodelling. As expected, the H&E staining results
showed that the aorta has remodelled in hypertensive mice. Furthermore, we found that
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exercise decreased the aorta remodelling in hypertensive mice after exercise. This is the
first time we found that exercise could benefit the vascular system by alleviating the
aorta remodelling in the R+ hypertensive mice model.

Along with the histology change, we looked into the mechanisms related to the
inflammation. Adipose tissue in a healthy individual maintains vascular homeostasis
through endocrine and paracrine pathways. However, an increase in adipose tissue
depots may lead to an imbalance in the levels of adipokines and can lead to
inflammation of adipose tissue during hypertension [99]. All the components of RAS
except renin are expressed in PVAT and Ang-II plays a major role in vascular
inflammation. PVAT is known to be the primary site of initial inflammation in
hypertension [100]. In the present study, we measured the pro-inflammatory cytokine,
IL-6, and the anti-inflammatory cytokine, IL-10, in both adipose tissue and PVAT. To
analyse the data precisely, we also normalized the concentration of cytokines to the
protein concentration of adipose tissue and PVAT, respectively. We did not find any
changes in the inflammatory cytokines in the adipose tissue of hypertensive mice, and
exercise did not have effects on the cytokine’s levels in the adipose tissue of
hypertensive mice. This could be due to the different cytokines we measured and could
also be due to a low number of animals in our study. Interestingly, we did find changes
in the PVAT of hypertensive mice. Data showed that the IL-10 level was decreased in
the PVAT in hypertensive mice. More importantly, after normalizing with the
concentration of PVAT, we found that the exercise decreased IL-6 level in PVAT of
hypertensive mice. These results suggest that exercise might have a beneficial effect on
the release of cytokines in PVAT of hypertensive mice, but not in the adipose tissue.
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To further investigate the underlying mechanisms of the inflammation, we performed
the flow cytometry to determine the numbers of macrophages and define the population
of M1/M2 macrophages in the adipose tissue and PVAT. Results showed that the total
macrophage numbers (F4/80 + cells) were increased in hypertensive mice, and exercise
could decrease the numbers. However, no significant differences were found. This
could be attributed to low animal numbers. As expected, the population of M1
macrophages (CD 86+ cells) was increased in the adipose tissue of hypertensive mice.
More importantly, exercise decreased the M1 population in the adipose tissue of
hypertensive mice. The population of M2 macrophages (CD206 + cells) was relatively
decreased in the adipose tissue of hypertensive mice, and exercise could increase the
number of M2 macrophages. Accordingly, the ratio of M1/M2 was significantly
increased in the adipose tissue of hypertensive mice. And excitingly, exercise could
significantly decrease the M1/M2 ratio in the adipose tissue of hypertensive mice.
Based on these results, exercise could provide beneficial effects on hypertensioninduced inflammation by modulating the polarization of macrophages in the adipose
tissue.

The same study was also performed in PVAT of hypertensive mice. The tendency
showed similar results in that the total macrophage numbers and M1 macrophages were
increased in hypertensive mice, and exercise could decrease their numbers. However,
there were no significant differences observed between different groups in total
macrophages, M1/M2 ratio. This could be due to the small size and low volume of
PVAT. In the future, we will pool the PVAT samples together in each group to gather
more cell numbers from PVAT. These data are inconsistent with our ELISA data
showing that exercise affected the release of cytokines in the PVAT but not in adipose
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tissue. Further studies are needed to investigate different cytokines and the mRNA and
protein levels of inflammatory pathways.

As mentioned previously, besides the adipose tissue and PVAT, plasma samples were
also collected to measure the cytokine levels by using the bio-plex assay. Since there
were 23 different cytokines detected, we picked several ones (IFN- γ, TNF- α, IL-10,
IL-12, IL-4, and IL-13) that have changed. Our data showed that IFN- γ level was
decreased in hypertensive mice when compared to the control. Exercise did not have
significant effects on the plasma level of IFN-γ even with a slight decrease. IFN-γ is a
proinflammatory cytokine involved in Th1-driven immune responses. However,
several studies have reported discrepant results regarding the role of IFN-γ in
autoimmune disease [101]. Moreover, IFN-γ exerts a protective effect because of its
anti-inflammatory activity and the ability to downregulate cartilage damage in an
experimental arthritis model [102]. These studies provide evidence to support our
results that IFN-γ could be decreased in hypertension and exercise might be able to
modulate the level of IFN-γ. However, for the pro-inflammatory cytokine, TNF-α, we
obtained contrary results that its level was decreased in hypertensive mice and exercise
had no effects on its level. More experiments are needed to confirm the results. There
were no significant changes in the level of IL-12 in hypertensive mice before or after
exercise observed. The level of anti-inflammatory cytokine IL-13 decreased
significantly in hypertensive mice when compared to the control group. Exercise could
slightly increase the plasma level of IL-13, however, no significant differences were
found between the hypertensive and exercised hypertensive groups. Interleukin-4 (IL4) is the prototypic type 2 immunoregulatory cytokine that can suppress the production
of many monocytes and macrophage pro-inflammatory mediators. In the present study,
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we found that IL-4 level is significantly decreased in hypertensive mice, which supports
the conception that anti-inflammatory cytokines are decreased in hypertension. We can
see a slight increase in IL-4 after exercise (no significant difference). Interestingly, IL10 level was slightly decreased in hypertensive mice (no significant difference) but
significantly increased after exercise. This agrees with our hypothesis that exercise
could provide beneficial effects on alleviating inflammation in hypertensive mice.

Along with the long-term effects of exercise, we also studied the short-term effect of
exercise (3 weeks) on the physiological parameters like the consumption of food, water,
and excretion of urine by the end of three weeks. There were no significant differences
between the groups through three weeks in all the three parameters. Our results suggest
that there was no effect of short-term exercise on the physiological parameters. The
effects of long-term exercise on the physiological parameters should be investigated in
the future,

In summary, we found that exercise had beneficial effects on body weights and aorta
remodelling. We also found some positive effects of exercise on the release of cytokines
in the adipose tissues, PVAT, and plasma that by decreasing the levels of proinflammatory cytokines and increasing the levels of anti-inflammatory cytokines might
be the mechanisms of through which exercise could modulate the polarization of
macrophages. However, there were also some contrasting data regarding the different
tissues and different cytokines. These effects remain unclear as the results depend on
the performance of the exercise, so better the training, the better we can expect the
beneficial effects of exercise. Also, the number of mice involved in the study was
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relatively small. More animals need to be added in the future study. On the other hand,
the control mice with exercise should be also included to investigate the exercise on the
bodyweight and inflammation without the hypertension factor. It would be interesting
to study and also expect a better effect of exercise in alleviating the inflammation in
hypertension of both the adipose tissue and perivascular adipose tissue if we can
overcome these limitations
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